BioPharma Credit PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOPCF research report →
Companywww.bpcruk.com
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
- CEO
- Pedro Gonzalez de Cosio
- IPO
- 2018
- HQ
- Exeter, GB
Price Chart
Valuation
- Market Cap
- $1.01B
- P/E
- 8.31
- P/S
- 7.67
- P/B
- 0.94
- EV/EBITDA
- 18.60
- Div Yield
- 10.40%
Profitability
- Gross Margin
- 93.51%
- Op Margin
- 92.51%
- Net Margin
- 92.62%
- ROE
- 11.29%
- ROIC
- 11.24%
Growth & Income
- Revenue
- $140.23M · 12.67%
- Net Income
- $129.89M · 6.31%
- EPS
- $0.11 · 10.00%
- Op Income
- $129.85M
- FCF YoY
- -18.60%
Performance & Tape
- 52W High
- $1.00
- 52W Low
- $0.83
- 50D MA
- $0.91
- 200D MA
- $0.91
- Beta
- 0.17
- Avg Volume
- 441.26K
Get TickerSpark's AI analysis on BOPCF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Our BOPCF Coverage
We haven't published any research on BOPCF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BOPCF Report →